UTHR
United Therapeutics Corporation
United Therapeutics Corporation (UTHR) is a biotechnology company focused on developing and commercializing therapies for pulmonary arterial hypertension and other conditions, with its strongest political signal being two holdings by former President Donald J. Trump valued up to $15,000 and active trading by two members of Congress.
Next filing → your inbox
Govt Dependence
15/100
Regulatory Density
85/100
Lobbying Intensity
0/100
Political Signal
NEUTRAL
BusinessWhat UTHR does
United Therapeutics Corporation is a biotechnology company that develops and commercializes products for the treatment of pulmonary arterial hypertension (PAH) and other serious diseases. Its revenue lines include sales of PAH therapies such as oral tablets, inhalable formulations, and subcutaneous infusions. The company also engages in research for organ manufacturing and cell-based therapies.
12 months past · 3 months futureUTHR activity timeline
Congress
buy
sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened
+ added
− trimmed
closed
holds
Bills
past action (this ticker)
upcoming markup (sector)
★ carveout (this ticker)
243 trading days ·
8 congressional trades shown
·
0 insider buys
·
11 13F filings
·
2 past bill actions
·
9 upcoming markups
Executive Branch ConflictsUTHR held by Trump-administration officials
1 cabinet/senior official reported UTHR positions in OGE Form 278 disclosures across 9 filings.
Donald J. Trump
President · White House
UNITED THERAPEUTICS CORP
Donald J. Trump
President · White House
UNITED THERAPEUTICS CORP
Donald J. Trump
President · White House
UNITED THERAPEUTICS CORP
Donald J. Trump
President · White House
UNITED THERAPEUTICS CORP
Donald J. Trump
President · White House
UNITED THERAPEUTICS CORP
Donald J. Trump
President · White House
United Therapeutics Corp
Donald J. Trump
President · White House
UNITED THERAPEUTICS CORP
Donald J. Trump
President · White House
UNITED THERAPEUTICS CORP
Donald J. Trump
President · White House
United Therapeutics Corp
Lifetime Government AwardsUTHR federal contracts by year
$20M
total awarded · 2010–2026
746
contracts on file
2023
peak year ($2M)
Top contracts by award amount
$366K
Department of Veterans Affairs
2021-12-07
TYVASO MEDICATION
$323K
Department of Veterans Affairs
2014-10-21
PHARMACEUTICAL DRUGS: TYVASSO REFILL KIT
$300K
Department of Veterans Affairs
2012-02-14
STANDING ORDER FOR TYVASO/REMODULIN, ETC. (RX FOR SPECIFIC PT.)
$299K
Department of Veterans Affairs
2023-05-19
TYVASO
$296K
Department of Veterans Affairs
2021-11-01
EO14042 TYVASCO
17 years · 746 contracts
Smart Money · 13F HoldingsHedge funds holding UTHR
$1.08T
Total UTHR held by tracked 13F funds
5
Funds with UTHR positions
Renaissance Technologies
$1059.67B
-6%
2026-03-31
Two Sigma Investments
$16.47B
+73%
2026-03-31
D.E. Shaw & Co.
$150M
+374%
8 overlap
2025-12-31
Citadel Advisors
$76M
-30%
8 overlap
2025-12-31
Bridgewater Associates
$31M
+302%
8 overlap
2025-12-31
Politicians Trading UTHRMembers of Congress with recent UTHR positions
2 politicians traded UTHR across 28 disclosed transactions totaling $2.1M (last 730 days).
Greed score = composite of trade frequency, volume & recency across the politician's entire history (not just UTHR). 0-30 LOW · 30-60 MID · 60+ HIGH.
Congressional TradesWho in Congress is trading UTHR
2025-10-31
Lisa C. McClain
sale
$1,001 - $15,000
2025-10-30
Lisa C. McClain
Purchase
$1,001 - $15,000
2025-10-30
Lisa C. McClain
Sale
$1,001 - $15,000
2025-10-30
Lisa C. McClain
purchase
$1,001 - $15,000
2025-10-31
Lisa C. McClain
Sale
$1,001 - $15,000
2025-10-30
Lisa C. McClain
sale
$1,001 - $15,000
2025-10-27
Michael T. McCaul
sale
$15,001 - $50,000
2025-10-27
Michael T. McCaul
Sale
$15,001 - $50,000
2025-08-22
Michael T. McCaul
sale
$50,001 - $100,000
2025-08-07
Michael T. McCaul
Purchase
$50,001 - $100,000
2025-08-22
Michael T. McCaul
Sale
$50,001 - $100,000
2025-08-07
Michael T. McCaul
purchase
$50,001 - $100,000
30+ trades on file · most recent 2025-11-21
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills Affecting UTHRLive legislation impacting this stock
S.827 · 119th
Supporting Rural Veterans Access to Healthcare Services Act
HR.2001 · 119th
Action for Dental Health Act
HR.1860 · 119th
Women Veterans Cancer Care Coordination Act
HR.2068 · 119th
Veterans Patient Advocacy Act
HR.2020 · 119th
New Mexico Rural Veteran Health Care Access Act
S.999 · 119th
Public Health Improvement Act
HR.2062 · 119th
To amend the Internal Revenue Code of 1986 to treat membership in a health care sharing ministry as a medical expense, and for oth
HR.2085 · 119th
Mental Health Research Accelerator Act of 2025
HR.2045 · 119th
Medicare Dental, Vision, and Hearing Benefit Act of 2025
HR.2048 · 119th
Metastatic Breast Cancer Access to Care Act
Political ProfileWhere UTHR sits in Washington
[object Object]
STRUCTURAL: No lobbying spend (get_political_influence.lobbying.total_income: $0), no donations, but federal contracts total $8.0M. EVIDENTIARY: Executive branch exposure includes two holdings by Donald J. Trump (get_executive_branch_exposure.by_ticker[0].holdings), and active congressional trading by two members (M001136, M001157) with multiple purchases and sales. Net: Mixed signals with no clear directional bias from political spending, but some high-level holdings and trading activity.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
Potential changes in healthcare reimbursement or drug pricing legislationCongress"Recent bill_impacts array shows 8 healthcare bills with impact_ratios up to 0.0003 affecting revenue."
Regulatory opportunities
-
Federal contracts with Department of Veterans Affairs for drug supplyDepartment of Veterans Affairs"get_government_precedent.federal_contracts_summary shows 291 contracts totaling $8,049,134.88 with agencies including Department of Veterans Affairs."
Capitol Hill AlliesChampions & critics
Member intelligence layer
Live signals + predictions for UTHR — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades UTHR
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord
Frequently AskedAbout UTHR & political exposure
Does United Therapeutics Corporation (UTHR) hold federal contracts?
Yes. United Therapeutics Corporation has 746 federal contract awards totaling $20,233,523, primarily from agencies including Department of Justice, Department of Veterans Affairs. See full contract list and amounts on this page.
Which Trump cabinet officials own UTHR stock?
1 Trump cabinet members or senior White House staff have disclosed holdings in UTHR on their OGE 278 financial disclosures, including Donald J. Trump. See the Cabinet Conflicts panel for details.
Has Congress traded UTHR stock?
96 congressional trades by 5 unique members of Congress, most recently on 2025-10-31. See the Congressional Trading panel for politician-by-politician breakdown.
What is UTHR political risk profile?
Government dependence: 15/100. Lobbying intensity: 0/100. Political signal: neutral. Donor party split: R 0% / D 0%.
How does GovGreed track UTHR political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. UTHR data is updated daily from these official federal sources.